search
Back to results

Epidural Stimulation After Spinal Cord Injury (ESL-SCI)

Primary Purpose

Spinal Cord Injuries

Status
Unknown status
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
EKSO+ES
Sponsored by
McGuire Research Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional device feasibility trial for Spinal Cord Injuries

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. A written clearance by the medical doctor to ensure that the participant is safely able to engage in the program.
  2. Participants who require assistance with activities of daily living, must have a caregiver or companion with them throughout their participation in the study.
  3. Participants will have to be 2 years post-injury with any level of injury below C5 and using wheelchair as the primary mode of mobility. The study is primarily exploratory, and all participants will be between 18-70 years old with SCI.
  4. Hip width (distance between two greater trochanters), upper leg length (greater trochanter to the lateral aspect of joint line of the knee joint) and lower leg length (lateral aspect of joint line of the knee joint to the bottom of the foot) that can fit the robotic suit.

Exclusion Criteria:

  1. Unhealed fracture in either lower or upper extremities
  2. Severe scoliosis, hip knee ROM or flexion knee contractures preventing positioning in an exoskeleton or plantarflexion deformity greater than 20 degrees.
  3. High resting blood pressure greater than 140/80 mmHg and or sudden hypotension upon standing as characterized by drop in blood pressure by 20 mmHg especially in persons with tetraplegia.
  4. Other medical conditions including cardiovascular disease, uncontrolled type II DM, uncontrolled hypertension, and those on insulin, pressures sores stage 3 or greater, or symptomatic urinary tract infection.
  5. Unable to fit in the device for any reason.
  6. Taking anti-coagulants or anti-platelet agents, including aspirin if unable to be off this medication for medical reasons.
  7. Implanted pacemakers and/or implanted defibrillator devices.
  8. Any condition that, in the judgment of the principal investigator or medical provider, precludes safe participation in the study and/or increases the risk of infection.
  9. Dual Energy X-ray Absorptiometry (DXA) T-Score less than -2.5. Scans done will include total body, dual hips and knees.
  10. Functional upper and lower extremity range of motion (ROM), strength, spasticity and skin integrity will also have assessed prior to enrollment in the program. The Modified Ashworth Scale will be used to ensure safety of the participants prior to engagement in the rehabilitation program. Participants with severe spasticity or limited ROM will be excluded in the trial. This will be done based on the manufacture's recommendation.
  11. Other exclusion criteria may include the followings

    • subjects with uncontrolled autonomic dysreflexia
    • subjects with concurrent severe neurological injuries other than SCI: MS, CP, TBI, stroke;
    • subjects with unresolved deep vein thrombosis (DVT);
    • subjects with prosthetic lower limbs;
    • subjects with psychiatric or cognitive impairments which will interfere with proper operation of both the spinal cord stimulator as well as the exoskeleton;
    • subjects with an unhealed spinal fracture or unstable spine; and
    • subjects with known cardiac pathology which precludes safe participation

Sites / Locations

  • Hunter Holmes McGuire VA Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

EKSO+ES

Arm Description

6 months of exoskeleton training with spinal cord epidural stimulation.

Outcomes

Primary Outcome Measures

Six minute-walk and 10-meter walk distance Tests
Walking distance and speed will also be determined
Surface electromyography of 6 different muscle groups
The EMG activity from 6 major leg muscles will be measured during locomotion

Secondary Outcome Measures

Systolic and Diastolic Blood Pressure
During sitting, standing and walking
Oxygen uptake using Portable Indirect Calorimetry
During sitting, standing and walking
Body composition assessment of fat mass and fat-free mass using dual energy x-ray absorptiometry (DXA)
Before and after training

Full Information

First Posted
September 23, 2019
Last Updated
October 2, 2019
Sponsor
McGuire Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT04105296
Brief Title
Epidural Stimulation After Spinal Cord Injury
Acronym
ESL-SCI
Official Title
Epidural Stimulation for Locomotion After Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 2020 (Anticipated)
Primary Completion Date
December 30, 2021 (Anticipated)
Study Completion Date
December 30, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
McGuire Research Institute

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of the current study is to determine the effects of applying epidural stimulation (ES) on motor control recovery in Veterans with SCI. The intervention will be accompanied with the use of a powered exoskeleton (EKSO®) for 6 months to facilitate standing and to produce step-like movement in persons with chronic motor complete (AIS A or B) SCI and level of injury below C5 . Walking speed, distance, muscle activation pattern as measured by surface EMG and walking parameters including stand-up time, walking time, distance will be considered primary outcome variables. Cardiovascular performance, as measured by resting blood pressure and heart rate, peak oxygen consumption during walking, energy expenditure, whole and regional body composition assessments will also be measured. The effects of training (ES+EKSO) on , and speed of walking will also be evaluated.
Detailed Description
Five veterans with chronic motor complete SCI (AIS A or B) will be recruited to participate in the current trial. The primary objective is to determine how implantation of an epidural stimulator can help to control movement in the leg muscles to stand and perform stepping. Participants will be trained using a robotic suit and parallel bars. The procedure of using epidural stimulation with the robotic suit is experimental. The participant will be scheduled to perform temporary implantation followed by permanent implantation. Seven days later, two 8-electrode arrays of Vectris lead will be implanted in an operating room. The research team will be responsible for helping the participants to trigger the paralyzed muscles from supine and sitting using for 5 days per week. Participants would be required to come for study visits twice daily for 2 hours per day. Each visit will last approximately 1 hour in the morning and 1 hour in the evening. During these visits, participants will practice walking with a robotic suit for 30-60 minutes followed by overground walking between parallel bars, or with a walker or crutches.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries

7. Study Design

Primary Purpose
Device Feasibility
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
5 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
EKSO+ES
Arm Type
Experimental
Arm Description
6 months of exoskeleton training with spinal cord epidural stimulation.
Intervention Type
Device
Intervention Name(s)
EKSO+ES
Intervention Description
6 months of exoskeleton training with epidural stimulation.
Primary Outcome Measure Information:
Title
Six minute-walk and 10-meter walk distance Tests
Description
Walking distance and speed will also be determined
Time Frame
6 months
Title
Surface electromyography of 6 different muscle groups
Description
The EMG activity from 6 major leg muscles will be measured during locomotion
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Systolic and Diastolic Blood Pressure
Description
During sitting, standing and walking
Time Frame
6 months
Title
Oxygen uptake using Portable Indirect Calorimetry
Description
During sitting, standing and walking
Time Frame
6 months
Title
Body composition assessment of fat mass and fat-free mass using dual energy x-ray absorptiometry (DXA)
Description
Before and after training
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: A written clearance by the medical doctor to ensure that the participant is safely able to engage in the program. Participants who require assistance with activities of daily living, must have a caregiver or companion with them throughout their participation in the study. Participants will have to be 2 years post-injury with any level of injury below C5 and using wheelchair as the primary mode of mobility. The study is primarily exploratory, and all participants will be between 18-70 years old with SCI. Hip width (distance between two greater trochanters), upper leg length (greater trochanter to the lateral aspect of joint line of the knee joint) and lower leg length (lateral aspect of joint line of the knee joint to the bottom of the foot) that can fit the robotic suit. Exclusion Criteria: Unhealed fracture in either lower or upper extremities Severe scoliosis, hip knee ROM or flexion knee contractures preventing positioning in an exoskeleton or plantarflexion deformity greater than 20 degrees. High resting blood pressure greater than 140/80 mmHg and or sudden hypotension upon standing as characterized by drop in blood pressure by 20 mmHg especially in persons with tetraplegia. Other medical conditions including cardiovascular disease, uncontrolled type II DM, uncontrolled hypertension, and those on insulin, pressures sores stage 3 or greater, or symptomatic urinary tract infection. Unable to fit in the device for any reason. Taking anti-coagulants or anti-platelet agents, including aspirin if unable to be off this medication for medical reasons. Implanted pacemakers and/or implanted defibrillator devices. Any condition that, in the judgment of the principal investigator or medical provider, precludes safe participation in the study and/or increases the risk of infection. Dual Energy X-ray Absorptiometry (DXA) T-Score less than -2.5. Scans done will include total body, dual hips and knees. Functional upper and lower extremity range of motion (ROM), strength, spasticity and skin integrity will also have assessed prior to enrollment in the program. The Modified Ashworth Scale will be used to ensure safety of the participants prior to engagement in the rehabilitation program. Participants with severe spasticity or limited ROM will be excluded in the trial. This will be done based on the manufacture's recommendation. Other exclusion criteria may include the followings subjects with uncontrolled autonomic dysreflexia subjects with concurrent severe neurological injuries other than SCI: MS, CP, TBI, stroke; subjects with unresolved deep vein thrombosis (DVT); subjects with prosthetic lower limbs; subjects with psychiatric or cognitive impairments which will interfere with proper operation of both the spinal cord stimulator as well as the exoskeleton; subjects with an unhealed spinal fracture or unstable spine; and subjects with known cardiac pathology which precludes safe participation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ashraf S Gorgey, PhD
Phone
8046755000
Ext
3386
Email
ashraf.gorgey@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Robert Trainer, MD
Email
Robert.Trainer@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ashraf S Gorgey, PhD
Organizational Affiliation
Hunter Holmes McGuire VA Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hunter Holmes McGuire VA Medical Center
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23249
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
IPD will be available in the form of published case reports as well as scientific presentations in national and international meetings.

Learn more about this trial

Epidural Stimulation After Spinal Cord Injury

We'll reach out to this number within 24 hrs